Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainDSL

DLL4 JAG2

2.24e-0441152PF01414
DomainDSL

DLL4 JAG2

2.24e-0441152SM00051
DomainAnaphylatoxin_comp_syst

C4A C4B

3.71e-0451152IPR018081
DomainDSL

DLL4 JAG2

3.71e-0451152PS51051
DomainNotch_ligand_N

DLL4 JAG2

3.71e-0451152IPR011651
DomainAnaphylatoxn_comp_syst_dom

C4A C4B

3.71e-0451152IPR001840
DomainMNNL

DLL4 JAG2

3.71e-0451152PF07657
DomainDSL

DLL4 JAG2

3.71e-0451152IPR001774
DomainHOOK

CCDC88B HOOK2

5.55e-0461152PF05622
DomainHook-related_fam

CCDC88B HOOK2

5.55e-0461152IPR008636
DomainANATO

C4A C4B

7.74e-0471152SM00104
DomainLEM/LEM-like_dom

LEMD2 ANKLE1

7.74e-0471152IPR011015
DomainLEM_dom

LEMD2 ANKLE1

7.74e-0471152IPR003887
DomainANAPHYLATOXIN_2

C4A C4B

7.74e-0471152PS01178
DomainANAPHYLATOXIN_1

C4A C4B

7.74e-0471152PS01177
DomainLEM

LEMD2 ANKLE1

7.74e-0471152PF03020
DomainANATO

C4A C4B

7.74e-0471152PF01821
DomainLEM

LEMD2 ANKLE1

7.74e-0471152PS50954
Domain-

LEMD2 ANKLE1

7.74e-04711521.10.720.40
DomainAnaphylatoxin/fibulin

C4A C4B

7.74e-0471152IPR000020
DomainMacrogloblnA2_thiol-ester-bond

C4A C4B

1.03e-0381152IPR019565
DomainDUF1669

FAM83C FAM83D

1.03e-0381152PF07894
DomainDUF1669

FAM83C FAM83D

1.03e-0381152IPR012461
DomainThiol-ester_cl

C4A C4B

1.03e-0381152PF10569
DomainMacrogloblnA2_CS

C4A C4B

1.03e-0381152IPR019742
DomainPH_dom-spectrin-type

SPTBN4 SPTBN5

1.32e-0391152IPR001605
DomainA2M

C4A C4B

1.64e-03101152PF00207
DomainA2M_N_2

C4A C4B

1.64e-03101152IPR011625
DomainA2M_comp

C4A C4B

1.64e-03101152IPR011626
DomainA2M_recep

C4A C4B

1.64e-03101152PF07677
DomainA2M_comp

C4A C4B

1.64e-03101152PF07678
DomainA2M_N

C4A C4B

1.64e-03101152PF01835
DomainA2M_N

C4A C4B

1.64e-03101152IPR002890
DomainA-macroglobulin_rcpt-bd

C4A C4B

1.64e-03101152IPR009048
DomainALPHA_2_MACROGLOBULIN

C4A C4B

1.64e-03101152PS00477
DomainA2M_N_2

C4A C4B

1.64e-03101152PF07703
DomainMacroglobln_a2

C4A C4B

1.64e-03101152IPR001599
Domain-

TARS2 NCOA5

1.99e-031111523.40.50.800
DomainPDZ

MAGI1 MAGIX SIPA1L3 DVL3 PREX1

2.23e-031481155SM00228
Domain-

MAGI1 MAGIX SIPA1L3 DVL3 PREX1

2.36e-0315011552.30.42.10
DomainPDZ

MAGI1 MAGIX SIPA1L3 DVL3 PREX1

2.43e-031511155PS50106
DomainPDZ

MAGI1 MAGIX SIPA1L3 DVL3 PREX1

2.50e-031521155IPR001478
DomainAnk

ANKRD9 ANKLE1 MIB2 KANK2 SOWAHA PPP1R12C

2.89e-032281156PF00023
DomainAnticodon-bd

TARS2 NCOA5

3.26e-03141152IPR004154
DomainAld_DH_CS_GLU

ALDH2 ALDH1B1

4.26e-03161152IPR029510
DomainEGF-like_dom

FRAS1 DLL4 JAG2 CELSR3 TENM3 PRF1

4.44e-032491156IPR000742
DomainANK

ANKRD9 ANKLE1 MIB2 KANK2 SOWAHA PPP1R12C

4.62e-032511156SM00248
DomainCadherin_CS

PCDHGA9 CDH22 CELSR3 CDH9

4.62e-031091154IPR020894
DomainANK_REPEAT

ANKRD9 ANKLE1 MIB2 KANK2 SOWAHA PPP1R12C

4.80e-032531156PS50088
DomainCarboxyPept-like_regulatory

CILP TENM3

4.81e-03171152IPR008969
DomainC345C

C4A C4B

4.81e-03171152SM00643
DomainAld_DH_CS_CYS

ALDH2 ALDH1B1

4.81e-03171152IPR016160
DomainAnkyrin_rpt-contain_dom

ANKRD9 ANKLE1 MIB2 KANK2 SOWAHA PPP1R12C

4.89e-032541156IPR020683
DomainANK_REP_REGION

ANKRD9 ANKLE1 MIB2 KANK2 SOWAHA PPP1R12C

4.89e-032541156PS50297
DomainCADHERIN_1

PCDHGA9 CDH22 CELSR3 CDH9

5.25e-031131154PS00232
DomainCadherin

PCDHGA9 CDH22 CELSR3 CDH9

5.25e-031131154PF00028
DomainTerpenoid_cyclase/PrenylTrfase

C4A C4B

5.39e-03181152IPR008930
DomainALDEHYDE_DEHYDR_CYS

ALDH2 ALDH1B1

5.39e-03181152PS00070
DomainALDEHYDE_DEHYDR_GLU

ALDH2 ALDH1B1

5.39e-03181152PS00687
DomainCADHERIN_2

PCDHGA9 CDH22 CELSR3 CDH9

5.41e-031141154PS50268
Domain-

PCDHGA9 CDH22 CELSR3 CDH9

5.41e-0311411542.60.40.60
DomainCA

PCDHGA9 CDH22 CELSR3 CDH9

5.58e-031151154SM00112
DomainAnkyrin_rpt

ANKRD9 ANKLE1 MIB2 KANK2 SOWAHA PPP1R12C

5.67e-032621156IPR002110
DomainCadherin-like

PCDHGA9 CDH22 CELSR3 CDH9

5.75e-031161154IPR015919
DomainNTR

C4A C4B

6.00e-03191152PF01759
Domain-

ALDH2 ALDH1B1

6.00e-031911523.40.605.10
DomainAldedh

ALDH2 ALDH1B1

6.00e-03191152PF00171
DomainNetrin_module_non-TIMP

C4A C4B

6.00e-03191152IPR018933
DomainVWC_out

FRAS1 JAG2

6.00e-03191152SM00215
DomainAld_DH_C

ALDH2 ALDH1B1

6.00e-03191152IPR016163
DomainAld_DH_N

ALDH2 ALDH1B1

6.00e-03191152IPR016162
DomainAld_DH/histidinol_DH

ALDH2 ALDH1B1

6.00e-03191152IPR016161
DomainAldehyde_DH_dom

ALDH2 ALDH1B1

6.00e-03191152IPR015590
Domain-

ALDH2 ALDH1B1

6.00e-031911523.40.309.10
DomainEGF_extracell

DLL4 JAG2 TENM3

6.03e-03601153IPR013111
DomainEGF_2

DLL4 JAG2 TENM3

6.03e-03601153PF07974
DomainCadherin

PCDHGA9 CDH22 CELSR3 CDH9

6.11e-031181154IPR002126
PathwayKEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION

DLL4 MIB2 JAG2 NEURL1

1.31e-079824M47866
PathwayREACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER

DLL4 MIB2 JAG2 NEURL1

1.38e-0615824M27202
PathwayREACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS

DLL4 MIB2 JAG2 NEURL1

7.18e-0622824M27210
PathwayREACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS

DLL4 MIB2 JAG2 NEURL1

1.23e-0525824M27879
PathwayREACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER

DLL4 MIB2 JAG2 NEURL1 HDAC10

2.12e-0558825M29616
PathwayREACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS

DLL4 MIB2 JAG2 NEURL1

2.97e-0531824M592
PathwayREACTOME_SIGNALING_BY_NOTCH2

DLL4 MIB2 JAG2 NEURL1

3.83e-0533824M604
PathwayREACTOME_SIGNALING_BY_NOTCH1

DLL4 MIB2 JAG2 NEURL1 HDAC10

6.93e-0574825M616
PathwayREACTOME_SIGNALING_BY_NOTCH3

DLL4 MIB2 JAG2 NEURL1

1.85e-0449824M618
PathwayWP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING

DLL4 JAG2 MFAP1

5.02e-0427823M39545
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

AHCTF1 SIPA1L3 POLR2B AGPAT2 DAXX RRP8 KANK2 DENND1A LSR SCML2 CNOT9 EIF4B RECQL5 FAM83D CHD6 EIF3A CROCC IMP3 PREX1 PPP1R12C

1.53e-0714971182031527615
Pubmed

Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.

DNHD1 SPTBN5 CELSR3 TENM3 MYH14 EIF4B EIF3A CROCC

2.66e-07187118826460568
Pubmed

Analysis of candidate genes on chromosome 20q12-13.1 reveals evidence for BMI mediated association of PREX1 with type 2 diabetes in European Americans.

NCOA5 CDH22 PREX1

7.56e-076118320650312
Pubmed

E-cadherin interactome complexity and robustness resolved by quantitative proteomics.

MAGI1 SIPA1L3 DVL3 KANK2 NLRP2 LSR TENM3 ARVCF EIF4B CCDC120 FAM110C

3.77e-065651181125468996
Pubmed

SR protein kinases promote splicing of nonconsensus introns.

SIPA1L3 MIB2 PKD1L2 CCDC88B KANK2 SPTBN4 CELSR3 EIF4B EIF3A

4.19e-06361118926167880
Pubmed

Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction.

C4A C4B

1.14e-052118222737222
Pubmed

Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.

C4A C4B

1.14e-052118216565498
Pubmed

Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations.

C4A C4B

1.14e-052118215998580
Pubmed

Structural polymorphism of murine C4 and its linkage to H-2.

C4A C4B

1.14e-05211827373044
Pubmed

High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's.

C4A C4B

1.14e-052118219062096
Pubmed

The chemical structure of the C4d fragment of the human complement component C4.

C4A C4B

1.14e-05211823696167
Pubmed

Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups.

C4A C4B

1.14e-05211821357031
Pubmed

Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s.

C4A C4B

1.14e-052118216098595
Pubmed

Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.

C4A C4B

1.14e-052118219933335
Pubmed

Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.

C4A C4B

1.14e-05211822459207
Pubmed

Antigen-induced B cell apoptosis is independent of complement C4.

C4A C4B

1.14e-052118217645767
Pubmed

Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura.

C4A C4B

1.14e-052118215787745
Pubmed

Anti-DNA autoreactivity in C4-deficient mice.

C4A C4B

1.14e-052118212207352
Pubmed

Neuropil contraction in relation to Complement C4 gene copy numbers in independent cohorts of adolescent-onset and young adult-onset schizophrenia patients-a pilot study.

C4A C4B

1.14e-052118230026462
Pubmed

A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B.

C4A C4B

1.14e-05211826559257
Pubmed

Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.

C4A C4B

1.14e-052118227758680
Pubmed

Synergistic association between two alcohol metabolism relevant genes and coronary artery disease among Chinese hypertensive patients.

ALDH2 ALDH1B1

1.14e-052118225047496
Pubmed

Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.

C4A C4B

1.14e-052118222387014
Pubmed

Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects.

C4A C4B

1.14e-052118234299197
Pubmed

Assessment of complement C4 gene copy number using the paralog ratio test.

C4A C4B

1.14e-052118220506482
Pubmed

Polymerase chain reaction based C4AQ0 and C4BQ0 genotyping: association with systemic lupus erythematosus in southwest Han Chinese.

C4A C4B

1.14e-052118212480675
Pubmed

Low C4, C4A and C4B gene copy numbers are stronger risk factors for juvenile-onset than for adult-onset systemic lupus erythematosus.

C4A C4B

1.14e-052118226800705
Pubmed

Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner.

C4A C4B

1.14e-052118223749435
Pubmed

Copy number variations of complement component C4 are associated with Behçet's disease but not with ankylosing spondylitis associated with acute anterior uveitis.

C4A C4B

1.14e-052118223918728
Pubmed

Murine complement C4 is not required for experimental autoimmune encephalomyelitis.

C4A C4B

1.14e-052118215390104
Pubmed

Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein.

C4A C4B

1.14e-05211823037333
Pubmed

Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.

C4A C4B

1.14e-052118211726230
Pubmed

Quantitative variations in the expression of the mouse serum antigen Ss and its sex-limited allotype Slp.

C4A C4B

1.14e-05211824216347
Pubmed

Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein.

C4A C4B

1.14e-05211821699796
Pubmed

Sequence determination of the thiolester site of the fourth component of human complement.

C4A C4B

1.14e-05211826950384
Pubmed

Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp.

C4A C4B

1.14e-05211822997024
Pubmed

Visual demonstration of the organization of the human complement C4 and 21-hydroxylase genes by high-resolution fluorescence in situ hybridization.

C4A C4B

1.14e-05211828660986
Pubmed

Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences.

C4A C4B

1.14e-05211823624865
Pubmed

Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain.

C4A C4B

1.14e-05211828428773
Pubmed

Determination of the loss of function complement C4 exon 29 CT insertion using a novel paralog-specific assay in healthy UK and Spanish populations.

C4A C4B

1.14e-052118221857912
Pubmed

Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.

C4A C4B

1.14e-052118224638111
Pubmed

Isolation of cDNA clones specifying the fourth component of mouse complement and its isotype, sex-limited protein.

C4A C4B

1.14e-05211826208559
Pubmed

The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement.

C4A C4B

1.14e-05211824514997
Pubmed

Transcriptional repression of C4 complement by hepatitis C virus proteins.

C4A C4B

1.14e-052118221345967
Pubmed

Telomere shortening in the esophagus of Japanese alcoholics: relationships with chromoendoscopic findings, ALDH2 and ADH1B genotypes and smoking history.

ALDH2 ALDH1B1

1.14e-052118223667679
Pubmed

The inheritance of susceptibility to the Gross leukemia virus in mice.

C4A C4B

1.14e-05211825919331
Pubmed

An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene.

C4A C4B

1.14e-05211823167981
Pubmed

The dichotomous size variation of human complement C4 genes is mediated by a novel family of endogenous retroviruses, which also establishes species-specific genomic patterns among Old World primates.

C4A C4B

1.14e-05211827545960
Pubmed

Insights on the relationship between complement component C4 serum concentrations and C4 gene copy numbers in a Western Australian systemic lupus erythematosus cohort.

C4A C4B

1.14e-052118230041577
Pubmed

Restriction fragment analysis of H-2 recombinant mouse strains with crossovers between E alpha and C4 genes.

C4A C4B

1.14e-05211822572548
Pubmed

The complement component C4 of mammals.

C4A C4B

1.14e-05211822302180
Pubmed

Complete cDNA sequence of the fourth component of murine complement.

C4A C4B

1.14e-05211823862104
Pubmed

The BS variant of C4 protects against age-related loss of white matter microstructural integrity.

C4A C4B

1.14e-052118234358307
Pubmed

Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d.

C4A C4B

1.14e-052118218360261
Pubmed

Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patients.

C4A C4B

1.14e-052118222151770
Pubmed

C4d-positive chronic rejection: a frequent entity with a poor outcome.

C4A C4B

1.14e-052118218091514
Pubmed

Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity.

C4A C4B

1.14e-052118229080553
Pubmed

Schizophrenia risk from complex variation of complement component 4.

C4A C4B

1.14e-052118226814963
Pubmed

Genes for murine fourth complement component (C4) and sex-limited protein (Slp) identified by hybridization to C4- and Slp-specific cDNA.

C4A C4B

1.14e-05211826589636
Pubmed

C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.

C4A C4B

1.14e-052118225339671
Pubmed

A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population.

C4A C4B

1.14e-052118217728371
Pubmed

Structure and organization of the C4 genes.

C4A C4B

1.14e-05211826149580
Pubmed

Sequence heterogeneity of murine complementary DNA clones related to the C4 and C4-Slp isoforms of the fourth complement component.

C4A C4B

1.14e-05211826149581
Pubmed

Comparative genomics, molecular evolution and computational modeling of ALDH1B1 and ALDH2.

ALDH2 ALDH1B1

1.14e-052118223247008
Pubmed

The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues.

C4A C4B

1.14e-052118212115608
Pubmed

Biochemistry and biology of anaphylatoxins.

C4A C4B

1.14e-05211823542363
Pubmed

C4 from C4-high and C4-low mouse strains have identical sequences in the region corresponding to the isotype-specific segment of human C4.

C4A C4B

1.14e-05211822387317
Pubmed

Promoter elements of the mouse complement C4 gene critical for transcription activation and start site location.

C4A C4B

1.14e-05211828132550
Pubmed

Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A.

C4A C4B

1.14e-05211822395880
Pubmed

Effects of Complement C4 Gene Copy Number Variations, Size Dichotomy, and C4A Deficiency on Genetic Risk and Clinical Presentation of Systemic Lupus Erythematosus in East Asian Populations.

C4A C4B

1.14e-052118226814708
Pubmed

cDNA clone spanning the alpha-gamma subunit junction in the precursor of the murine fourth complement component (C4).

C4A C4B

1.14e-05211826192448
Pubmed

Complete primary structure of human C4a anaphylatoxin.

C4A C4B

1.14e-05211826167582
Pubmed

Identification of the size and antigenic determinants of the human C4 gene by a polymerase chain-reaction-based amplification method.

C4A C4B

1.14e-052118216908004
Pubmed

Slp is an essential component of an EDTA-resistant activation pathway of mouse complement.

C4A C4B

1.14e-05211821438267
Pubmed

Structural studies on the murine fourth component of complement (C4). IV. Demonstration that C4 and Slp are encoded by separate loci.

C4A C4B

1.14e-05211827365238
Pubmed

Skeletrophin, a novel ubiquitin ligase to the intracellular region of Jagged-2, is aberrantly expressed in multiple myeloma.

MIB2 JAG2

1.14e-052118215920166
Pubmed

Genetic deficiency of complement isoforms C4A or C4B predicts improved survival of metastatic renal cell carcinoma.

C4A C4B

1.14e-052118219150565
Pubmed

Interaction between the labile binding sites of the fourth (C4) and fifth (C5) human complement proteins and erythrocyte cell membranes.

C4A C4B

1.14e-05211827391573
Pubmed

Elevated levels of endogenous apoptotic DNA and IFN-alpha in complement C4-deficient mice: implications for induction of systemic lupus erythematosus.

C4A C4B

1.14e-052118217506029
Pubmed

Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection.

C4A C4B

1.14e-052118217971360
Pubmed

Low C4 gene copy numbers are associated with superior graft survival in patients transplanted with a deceased donor kidney.

C4A C4B

1.14e-052118223715124
Pubmed

Identification of the 5'-flanking regulatory region responsible for the difference in transcriptional control between mouse complement C4 and Slp genes.

C4A C4B

1.14e-05211823464002
Pubmed

Complete nucleotide and derived amino acid sequences of the fourth component of mouse complement (C4). Evolutionary aspects.

C4A C4B

1.14e-05211822993295
Pubmed

Clinical features of patients with homozygous complement C4A or C4B deficiency.

C4A C4B

1.14e-052118229928053
Pubmed

Role of aldehyde dehydrogenases, alcohol dehydrogenase 1B genotype, alcohol consumption, and their combination in breast cancer in East-Asian women.

ALDH2 ALDH1B1

1.14e-052118232300124
Pubmed

Analysis of C4 and the C4 binding protein in the MRL/lpr mouse.

C4A C4B

1.14e-052118217971229
Pubmed

Genetic deficiency of C4 presenting with recurrent infections and a SLE-like disease. Genetic and immunologic studies.

C4A C4B

1.14e-05211826881182
Pubmed

Identification of the site of sulfation of the fourth component of human complement.

C4A C4B

1.14e-05211823944109
Pubmed

Partial C4 deficiency in juvenile idiopathic arthritis patients.

C4A C4B

1.14e-052118217921792
Pubmed

Complement activation and complement receptors on follicular dendritic cells are critical for the function of a targeted adjuvant.

C4A C4B

1.14e-052118221880985
Pubmed

Amino acid sequence around the thiol and reactive acyl groups of human complement component C4.

C4A C4B

1.14e-05211826978711
Pubmed

Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD.

C4A C4B

1.14e-052118235898513
Pubmed

A region rich in aspartic acid, arginine, tyrosine, and glycine (DRYG) mediates eukaryotic initiation factor 4B (eIF4B) self-association and interaction with eIF3.

EIF4B EIF3A

1.14e-05211828816444
Pubmed

Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice.

C4A C4B

1.14e-052118233353966
Pubmed

Sequence comparison of alleles of the fourth component of complement (C4) and sex-limited protein (Slp).

C4A C4B

1.14e-05211823008092
Pubmed

Borrelia burgdorferi outer surface protein C (OspC) binds complement component C4b and confers bloodstream survival.

C4A C4B

1.14e-052118228873507
Pubmed

The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.

C4A C4B

1.14e-05211826609966
Pubmed

Heterogeneity and linkage of equine C4 and steroid 21-hydroxylase genes.

C4A C4B

1.14e-05211822900855
Pubmed

Studies on the murine Ss protein: demonstration that the Ss protein is functionally the fourth component of complement.

C4A C4B

1.14e-0521182276882
Pubmed

Differential regulation of Notch ligands in dendritic cells upon interaction with T helper cells.

DLL4 JAG2

1.14e-052118221352254
Cytoband22q11.21

ARVCF RIMBP3C RIMBP3B GP1BB

2.07e-04111119422q11.21
GeneFamilyEF-hand domain containing|Spectrins

SPTBN4 SPTBN5

3.71e-0477721113
GeneFamilyLEM domain containing

LEMD2 ANKLE1

3.71e-0477721087
GeneFamilyPDZ domain containing

MAGI1 MAGIX SIPA1L3 DVL3 PREX1

4.77e-041527751220
GeneFamilyAnkyrin repeat domain containing

ANKRD9 ANKLE1 MIB2 KANK2 SOWAHA PPP1R12C

5.80e-04242776403
GeneFamilyC3 and PZP like, alpha-2-macroglobulin domain containing

C4A C4B

6.32e-0497721234
GeneFamilyCD molecules|Type II classical cadherins

CDH22 CDH9

1.35e-03137721186
GeneFamilyAldehyde dehydrogenases

ALDH2 ALDH1B1

2.92e-0319772398
CoexpressionGSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP

MAGIX TTC36 MIB2 TNFRSF10B NRBP2 ZNF436-AS1 MYH14 CTF1

2.38e-061911178M6076
ToppCellBiopsy_IPF-Mesenchymal-Mesothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type

COL6A2 FRAS1 TENM3 PAPPA C4A C4B FAM110C

1.07e-062001187553386523fd8f8f36617a0d81032224b7ddce442
ToppCelldroplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAGI1 DVL3 TNFRSF10B ZDHHC20 RNF125 FAM83D

1.37e-061311186419a0a83b38eaea890d065c3f252ef83c2d37b5b
ToppCellfacs-Aorta-Heart-24m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TTC36 ANKLE1 PKD1L2 FAM83C URAD HAO2

3.25e-0615211861da25f913b0fb167f66e539aef509ca44893a878
ToppCellfacs-Aorta-Heart-24m-Mesenchymal-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TTC36 ANKLE1 PKD1L2 FAM83C URAD HAO2

3.25e-061521186254f92d9e6c9c6404f3875dd54d655af87854b14
ToppCellremission-unassigned|remission / disease stage, cell group and cell class

CAPN12 NOL3 AARD SRCAP FAM83D CCDC120

3.50e-0615411864130769829b838cc8a075c87ff6c187f0f507f8b
ToppCell18-Distal-Epithelial-Basal_cell|Distal / Age, Tissue, Lineage and Cell class

MYCL KREMEN2 NLRP2 DENND1A ALDH1B1 FAM110C

4.06e-061581186183f445967e09e871c93d8e94781ed9fec894169
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-erythrocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ANKRD9 ANKLE1 NCOA4 KANK2 ARVCF PKLR

5.78e-061681186360cd756067c8cfb6a78301674758eb5fac52c23
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ANKRD9 ANKLE1 NCOA4 KANK2 ARVCF PKLR

5.78e-061681186d791116040a9d3ea0485d68c974340116073986b
ToppCellfacs-Aorta-Heart-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TTC36 ANKLE1 FAM83C SOWAHA URAD HAO2

5.98e-061691186daed9083ee05c220365200328c2c50047fe21efd
ToppCellfacs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MAGI1 DLL4 MAGIX TNFRSF10B JAG2 RNF125

6.61e-061721186c84cab89c97d647b8a256fd08e33d9102810febd
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

COL6A2 ALKBH7 EMILIN1 FAM83D ALDH1B1 PPP1R12C

7.30e-061751186c6c0196875f3b5293083cda6718300806a801941
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

COL6A2 ALKBH7 EMILIN1 FAM83D ALDH1B1 PPP1R12C

7.30e-06175118682c4d1edaa0d3b82d3ef4676d6f6516104a2656a
ToppCell390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells)

COL6A2 FRAS1 KANK2 EMILIN1 TENM3 PAPPA

8.58e-061801186137fc14859c89e1ecd98bee388bb58c04b835847
ToppCell390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells)

COL6A2 FRAS1 KANK2 EMILIN1 TENM3 PAPPA

8.58e-061801186cd6790de050151fedfa2c5ea6ad58b72665414b2
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

FRAS1 AARD WWC2 LSR MYH14 SLC22A31

1.52e-0519911861c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b
ToppCellTransplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X

COL6A2 FRAS1 KANK2 EMILIN1 PAPPA FAM110C

1.56e-052001186c082bc21ec7c5323439d108ea8aea510e1113c3f
ToppCelldroplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAGI1 JAG2 ZDHHC20 RNF125 FAM83D

2.16e-0512611854eeea015efe17e0aae5bd76b71fa70b5149dfada
ToppCellLPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAM83C MYH14 CTF1 HOOK2 SLC22A31

2.24e-0512711855b0adbcafad31a6759c9bdce2f7f9591a8edc450
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Gpr139|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

COL6A2 CCDC88B EMILIN1 SPTBN5 ALDH1B1

2.90e-051341185917b8951dd4c870b6b92f2e73e02dac884330c30
ToppCellsaliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

KDM5D SOWAHA CELSR3 PRF1 HDAC10

4.98e-05150118553de595376a9fc92491dfd58ff25938b0bf79903
ToppCellsaliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

KDM5D SOWAHA CELSR3 PRF1 HDAC10

4.98e-051501185e4b40b3243ed26d0c46bf196ac06e148834e7ed2
ToppCelldroplet-Liver-LIVER_HEPATOCYTES-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A2 CILP PCDHGA9 PAPPA ARHGAP45

5.30e-051521185d5ba87b5d34e52cef8475befafea962d70fa8a1d
ToppCelldroplet-Liver-LIVER_HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A2 CILP PCDHGA9 PAPPA ARHGAP45

5.30e-051521185d88d68a788a3256671ebbc06e104833f1f58f07d
ToppCellPND07-28-samps-Epithelial-Epithelial-non_alveolar-Club_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass

MYCL MAGIX TTC36 NRBP2 CCDC120

7.17e-051621185aed15eef32419b8a4e2afdb9776c2bf2802e96f1
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CCDC88B RNF125 CELSR3 PRF1 ARHGAP45

7.60e-051641185649e42d9cfdec2f7771d1e938b516e46e7d07078
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CCDC88B RNF125 CELSR3 PRF1 ARHGAP45

7.60e-051641185ba85f7b21ae34e285d286ada24715885ca6329f7
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-NK-NK-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CAPN12 NLRP2 LSR RNF125 PRF1

9.00e-051701185aaf29c2d4de172d366cbfc863bc741941667dde1
ToppCellnormal-na-Lymphocytic_NK-natural_killer_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

SPTBN5 RNF125 ARVCF PRF1 FAM110C

9.25e-051711185d339840626211a7bf1a9eb8f14d6c9509ab05e1c
ToppCellEntopeduncular-Macroglia-POLYDENDROCYTE-P2-Tnr|Entopeduncular / BrainAtlas - Mouse McCarroll V32

MYCL SIGLEC15 DMC1 GP1BB

9.65e-059011846adc78899a08d48da8ed4618ecf866c9ed9be059
ToppCellEntopeduncular-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)|Entopeduncular / BrainAtlas - Mouse McCarroll V32

MYCL SIGLEC15 DMC1 GP1BB

9.65e-05901184a74f8172780adc1410e36e2718412010ee0ebf1f
ToppCellEntopeduncular-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32

MYCL SIGLEC15 DMC1 GP1BB

9.65e-05901184909ad62d175b657d8e541b0981ce8fed0ba7ed6c
ToppCellEntopeduncular-Macroglia-POLYDENDROCYTE-P2|Entopeduncular / BrainAtlas - Mouse McCarroll V32

MYCL SIGLEC15 DMC1 GP1BB

9.65e-05901184936c5078677ec934f3049d8aa5a14d930aa2e6dc
ToppCell3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CAPN12 RAB3GAP1 PRF1 GUCY2D PREX1

1.06e-041761185dbc4f64cd39b229f2355ca1d0215cc7f6a767dce
ToppCellPND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ANKLE1 DMC1 SCML2 CDH22 TENM3

1.09e-0417711853e149bff1f1b393a7abe98984e37981c8296f95d
ToppCellnormal-na-Lymphocytic_NK-T_mait-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

CAPN12 COL6A2 KDM5D RNF125 PRF1

1.18e-041801185e66a8a61b3576ac37de7c559d16d4ed4f7a2fc78
ToppCell3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CAPN12 RAB3GAP1 PRF1 GUCY2D PREX1

1.21e-041811185ee1c5af8ed75dd8a0ed3152ba5b9a42d2a8c2ae4
ToppCellPND10-Immune-Immune_Myeloid-Dendritic-cDC1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYCL LEMD2 CCDC88B CNOT9 ARHGAP45

1.27e-041831185ab38264daddccdf5ffb75ff2210b27423eca6bc0
ToppCellPND10-Immune-Immune_Myeloid-Dendritic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYCL LEMD2 CCDC88B CNOT9 ARHGAP45

1.27e-041831185e4911601dca2c0ecb448cdb6b222dedfc0c8bf6c
ToppCellPND10-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYCL LEMD2 CCDC88B CNOT9 ARHGAP45

1.27e-041831185263bfa1d8a7314bc3156c735c403c3bab8ea4dac
ToppCellIPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class

COL6A2 PAPPA C4A C4B FAM110C

1.27e-0418311857df20e3172a1220ff427f30181f4f0c3b7fe2d42
ToppCell3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL6A2 AARD KANK2 EMILIN1 ALDH1B1

1.27e-0418311856b5eef96b28911c752a8b6c0975918c4572cec38
ToppCell3'-Child09-12-SmallIntestine-Mesenchymal-myocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL6A2 AARD KANK2 EMILIN1 ALDH1B1

1.30e-0418411855cfc19ffb9f074bdf0d81c86e212a708ec141631
ToppCellPBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

UBXN6 NCOA4 KANK2 C4A C4B

1.34e-041851185d685a5a2e525db2eba449cfa1e5cd54eb36162a8
ToppCellPBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

UBXN6 NCOA4 KANK2 C4A C4B

1.34e-0418511855d8d6fd7800f76ee3aa5cef95241d8e6d7e8db04
ToppCellPBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

UBXN6 NCOA4 KANK2 C4A C4B

1.34e-041851185100b5afdf3c6ab07ffc493f7883f5a7b31c59184
ToppCellCOVID-19_Severe-Hematopoietic_R|COVID-19_Severe / Disease group, lineage and cell class

UBXN6 NCOA4 KANK2 C4A C4B

1.34e-04185118530f064ab7c3890e6f419a845276b145112e78f52
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_bright-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CAPN12 FRAS1 MIB2 RNF125 PRF1

1.34e-0418511853b2da51aec057b462749ae39afb8f253afcf38d5
ToppCellPBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

UBXN6 NCOA4 KANK2 C4A C4B

1.34e-041851185f3b1907c3b6f930bc161f46efce5e143babab507
ToppCellPBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

UBXN6 NCOA4 KANK2 C4A C4B

1.34e-04185118544ce50cb99df8ffc50eba311adcf688477618659
ToppCellPBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

UBXN6 NCOA4 KANK2 C4A C4B

1.34e-04185118517542ccd52a821c9e99b1a7469e80502e764b3fd
ToppCellCOVID-19_Severe-Hematopoietic_R-RBC|COVID-19_Severe / Disease group, lineage and cell class

UBXN6 NCOA4 KANK2 C4A C4B

1.34e-0418511853ed6090b822c6d1d400a421236cddc7511743932
ToppCelldroplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAGI1 DLL4 PCDHGA9 AGPAT2 CCDC120

1.37e-041861185f23f21781a758541f59c06efa7739d26a03fb478
ToppCelldroplet-Lung-LUNG-30m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAGI1 DLL4 PCDHGA9 AGPAT2 CCDC120

1.37e-0418611850de87109da9324c597fadf2eb782f0f158afe832
ToppCelldroplet-Spleen-nan-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SCML2 ARVCF PKLR CTF1 RAB4A

1.41e-041871185c81d11d9fdc22dc39222f62c2888025c2e8c3e65
ToppCell368C-Lymphocytic-NK_cells-NK_cell_D3|368C / Donor, Lineage, Cell class and subclass (all cells)

CAPN12 TARS2 NLRP2 RNF125 TRABD

1.44e-041881185ecc2364d946f97ae0212fd6739960c9fc75e4919
ToppCellCOPD-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class

COL6A2 TENM3 C4A C4B FAM110C

1.44e-041881185159d63ecc3653a7449fc6acefd6ef0464845260e
ToppCell3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL6A2 AARD KANK2 EMILIN1 TENM3

1.48e-04189118563449d9f1e78ff2bc8786eb88a0d177fe30c7f4d
ToppCellfacs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAGI1 DLL4 TNFRSF10B JAG2 RNF125

1.52e-04190118538a815abf0ac5cac6071737cadc54a514f62d37d
ToppCellfacs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAGI1 DLL4 TNFRSF10B JAG2 RNF125

1.52e-041901185bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e
ToppCellfacs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAGI1 DLL4 TNFRSF10B JAG2 RNF125

1.52e-041901185d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d
ToppCellsevere_COVID-19-RBC|severe_COVID-19 / disease group, cell group and cell class (v2)

ANKRD9 UBXN6 ANKLE1 NCOA4 KANK2

1.52e-0419011853a5723c2daf58c1932edd70910db4b8b30f63f42
ToppCelldroplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYCL LSR MYH14 CTF1 FAM110C

1.55e-041911185b94e66ac71e73f46b0323d424e7b8b906751d584
ToppCellsevere_COVID-19-RBC|World / disease group, cell group and cell class (v2)

ANKRD9 UBXN6 ANKLE1 NCOA4 KANK2

1.59e-0419211851b4e28fd2e3d70ab48dbe96b280d35395889fbe2
ToppCell10x5'v1-week_14-16-Lymphocytic_NK-T_NK-mature_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

CAPN12 MIB2 RNF125 PRF1 FAM110C

1.59e-041921185e48bbcb97c113f323ad4db96bd10d593b9206923
ToppCellwk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

ANKRD9 UBXN6 ANKLE1 KDM5D NCOA4

1.63e-041931185be75abfdf5301cf33df8ee9ed92504d44fdf19a6
ToppCelllymphoid-NK_cell-NK_cell|World / Lineage, cell class and subclass

CAPN12 COL6A2 MIB2 RNF125 PRF1

1.67e-0419411857f5adc18e632109694446b8eb1543cbae62dccbe
ToppCelllymphoid-NK_cell|World / Lineage, cell class and subclass

CAPN12 COL6A2 MIB2 RNF125 PRF1

1.67e-0419411854bf5a140be8691e4ec99d7ee15588fd48acd6fb5
ToppCellfrontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Cytl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

DLL4 TRIM14 LSR RNF125

1.69e-0410411845d9cd14e53a2f1060e528abf6c0694be9d72c356
ToppCell3'-GW_trimst-1-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL6A2 CILP KANK2 EMILIN1 ALDH2

1.71e-04195118519347b7e8d3ea67e0fddd948078abcab9d364a2d
ToppCell3'-GW_trimst-1-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL6A2 CILP KANK2 EMILIN1 ALDH2

1.71e-04195118555b4030f078173b0136990fae87b6eaf44c58f33
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

RNF125 PRF1 TRABD ARHGAP45 PREX1

1.71e-04195118536c784709ee32174e05b457500339c3b8eee3244
ToppCellParenchymal-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

FRAS1 TENM3 C4A C4B FAM110C

1.79e-04197118588a86286b9c3ea3b076d7464faec42d0392ee7f8
ToppCellParenchymal-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

FRAS1 TENM3 C4A C4B FAM110C

1.79e-0419711852773d2eb5f232a7e49da116efffcb6bf5eb90810
ToppCellCOVID-19-kidney-T-cells-1|kidney / Disease (COVID-19 only), tissue and cell type

CCDC88B RNF125 PRF1 ARHGAP45 PREX1

1.79e-0419711859bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e
ToppCellControl-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class

NCOA4 EIF4B EIF3A ALDH2 ARHGAP45

1.79e-041971185eb7610c9496a95a5fd866e16abcbc39b83abe617
ToppCelldistal-3-mesenchymal-Fibromyocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

COL6A2 EMILIN1 SOWAHA FAM83D ALDH1B1

1.84e-041981185dc93886439a378a0c71e99acb8081bfb6b6d467b
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

MYCL AARD WWC2 LSR MYH14

1.84e-0419811855a85c286f79cde5811d2595a3397c6fb7685adee
ToppCell3'-GW_trimst-1-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

AGPAT2 LSR NEURL1 FAM110C URAD

1.84e-041981185f95f38cc747fb3549a791288bf8d0518c049ac96
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

AARD TRIM14 LSR MYH14 SLC22A31

1.84e-0419811858d9858dcb21f20d0c040b22a2cae543eaebd54bc
ToppCellCOVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type

COL6A2 FRAS1 EMILIN1 TENM3 PAPPA

1.84e-041981185df3de77216f5c5d6141ec44d01c56b942f611838
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

AARD TRIM14 LSR MYH14 SLC22A31

1.84e-041981185f006d68e6c51923be7772eea118546a5762e8a5e
ToppCell3'-GW_trimst-1-SmallIntestine-Epithelial-goblet|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

AGPAT2 LSR NEURL1 FAM110C URAD

1.84e-0419811859c5d7852f03468394e726c444cac92a043fc6d0e
ToppCell5'-GW_trimst-1.5-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LSR MYH14 NEURL1 FAM110C URAD

1.88e-041991185fb9550bbb1fa206c3132e0a21a646eedb41c281a
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

AARD TRIM14 LSR MYH14 SLC22A31

1.88e-041991185180b3997174fd63bdf3b828063a13483eb4cab29
ToppCell5'-GW_trimst-1.5-SmallIntestine-Epithelial-goblet|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LSR MYH14 NEURL1 FAM110C URAD

1.88e-041991185440f47e320c75f49ef47139b46962de68cee8320
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_1-AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

AARD WWC2 LSR MYH14 SLC22A31

1.88e-0419911858c9ec5f05b79cf5ae1bf7aade603c171fb0226a9
ToppCellBiopsy_Control_(H.)-Mesenchymal-Mesothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type

COL6A2 TENM3 PAPPA C4A C4B

1.88e-041991185ca970114b5aef4518ce580897a62ac88688b2671
ToppCellLPS_anti-TNF-Hematopoietic_Erythro-Megakary|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ANKRD9 ANKLE1 NCOA4 PKLR GP1BB

1.88e-0419911856c174dbcc25b980f10a3d1dfe39e613acac73bb6
ToppCellLPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ANKRD9 ANKLE1 NCOA4 PKLR GP1BB

1.88e-041991185284ee9632413f6404fc0b0c7c393ad813db834f2
ToppCellLPS_only-Epithelial_alveolar-AT_1-AT1|LPS_only / Treatment groups by lineage, cell group, cell type

AARD TRIM14 LSR MYH14 SLC22A31

1.88e-041991185ccdde5d4bcc72f230a1dd2544ee7f4dfb98a5e80
ToppCell343B-Epithelial_cells-Epithelial-D_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

ALKBH7 AGPAT2 LSR IMP3 SLC22A31

1.92e-04200118505e61fa111f0f87f660cea2e69485fab553d3861
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

COL6A2 CILP ARHGEF17 KANK2 GP1BB

1.92e-0420011859169a9ec8e9ab95d90a64c5a19ac666a5cf82313
ToppCell10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

COL6A2 FRAS1 ARHGEF17 EMILIN1 PAPPA

1.92e-042001185ad3fb8ef0be45032369d1325024787fbe1dfb8d6
ToppCell343B-Epithelial_cells-Epithelial-D_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

ALKBH7 AGPAT2 LSR IMP3 SLC22A31

1.92e-04200118546d0ce6a747e7daa70ae27ea7fd519624a7e279b
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

FRAS1 WWC2 LSR MYH14 SLC22A31

1.92e-042001185ddfb1f006365bf16203ee49f20200f68220cc288
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

FRAS1 WWC2 LSR MYH14 SLC22A31

1.92e-0420011858683445ad5b70748c4a1f12eb77d47623085147e
ToppCellsevere-NK_CD56bright|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

CAPN12 FRAS1 MIB2 RNF125 PRF1

1.92e-0420011852e67068b98696c313b815a2f0c98643f892e8bc0
ToppCellLPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type

COL6A2 CILP ARHGEF17 KANK2 GP1BB

1.92e-0420011858c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f
ToppCellLPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ANKRD9 ANKLE1 NCOA4 PKLR GP1BB

1.92e-042001185f99e214eb680fd82a33f2b1524fbfca265d1cc42
ToppCellLPS_IL1RA-Hematopoietic_Erythro-Megakary|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ANKRD9 ANKLE1 NCOA4 PKLR GP1BB

1.92e-042001185d85074b362b11e5a523a5325d203a61aa2759a7a
Drugaspirin, USP; Up 200; 100uM; PC3; HT_HG-U133A

MYCL CILP SRCAP ARHGEF17 ARVCF PRF1 NEURL1 PAPPA HAO2

8.11e-0719811694428_UP
DrugTrolox [53188-07-1]; Down 200; 16uM; MCF7; HT_HG-U133A

KREMEN2 SIPA1L3 PI4K2A SRCAP TRIM14 RAB3GAP1 TENM3 ARVCF

7.51e-0619611686007_DN
DrugPivampicillin [33817-20-8]; Down 200; 8.6uM; MCF7; HT_HG-U133A

KREMEN2 SIPA1L3 PI4K2A TNFRSF10B SRCAP WWC2 SCML2 TRABD

7.51e-0619611685465_DN
Drugaspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A_EA

CHMP6 KREMEN2 SIPA1L3 TNFRSF10B TRIM14 DMC1 RECQL5 CROCC

7.79e-061971168984_UP
DrugTadjakonine [11087-94-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A

KREMEN2 DUSP8 SRCAP ARHGEF17 ARVCF MYH14 RECQL5

6.23e-0519411674424_DN
DrugEpicatechin-(-) [154-23-4]; Up 200; 13.8uM; HL60; HT_HG-U133A

ATF7 PI4K2A SRCAP RECQL5 NEURL1 PKLR PAPPA

6.44e-0519511672160_UP
DrugCalycanthine [595-05-1]; Down 200; 11.6uM; PC3; HT_HG-U133A

MYCL SIPA1L3 SRCAP TRIM14 LSR RECQL5 ALDH1B1

6.44e-0519511675744_DN
DrugThonzonium bromide [553-08-2]; Down 200; 6.8uM; MCF7; HT_HG-U133A

MAGI1 CHMP6 SIPA1L3 TRIM14 TENM3 RECQL5 ALDH1B1

6.44e-0519511676457_DN
DrugDihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; PC3; HT_HG-U133A

MYCL GPR37 AGPAT2 PI4K2A SRCAP RNF125 MYH14

6.65e-0519611675751_DN
DrugClorgyline hydrochloride [17780-75-5]; Down 200; 13uM; MCF7; HT_HG-U133A

GPR37 KREMEN2 UBXN6 PI4K2A SRCAP DMC1 RECQL5

6.65e-0519611675005_DN
DrugMefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A

DUSP8 AGPAT2 PI4K2A SRCAP TRIM14 SCML2 ARHGAP45

6.65e-0519611671821_DN
DrugClebopride maleate [84370-95-6]; Down 200; 8.2uM; MCF7; HT_HG-U133A

AGPAT2 UBXN6 TNFRSF10B CNOT9 ARVCF TRABD RECQL5

6.87e-0519711672646_DN
DrugTriamterene [396-01-0]; Up 200; 15.8uM; MCF7; HT_HG-U133A

MYCL KREMEN2 DVL3 SRCAP RNF125 MYH14 RECQL5

6.87e-0519711676010_UP
DrugCarbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A

SIPA1L3 TRIM14 DMC1 CELSR3 TRABD RECQL5 ALDH1B1

6.87e-0519711673250_DN
Drug(R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A

MAGI1 KREMEN2 SIPA1L3 PI4K2A SRCAP ARHGEF17 TENM3

7.09e-0519811676096_DN
Drug16-phenyl tetranor Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A

MAGI1 GPR37 TNFRSF10B NEURL1 ALDH1B1 CROCC ARHGAP45

7.09e-0519811677541_UP
DrugCeftazidime pentahydrate [78439-06-2]; Down 200; 6.2uM; MCF7; HT_HG-U133A

MAGI1 GPR37 KREMEN2 TNFRSF10B RAB3GAP1 MYH14 TRABD

7.32e-0519911675473_DN
DrugPHA-00846566E [724718-26-7]; Up 200; 10uM; MCF7; HT_HG-U133A

SRCAP ARHGEF17 TRIM14 DMC1 RAB3GAP1 RNF125 CROCC

7.32e-0519911677081_UP
DrugNitrofurantoin [67-20-9]; Up 200; 16.8uM; HL60; HT_HG-U133A

MYCL ATF7 SIPA1L3 AGPAT2 SRCAP CELSR3 NEURL1

7.32e-0519911672341_UP
Drugazathioprine, USP; Down 200; 100uM; MCF7; HG-U133A

GPR37 KDM5D NLRP2 CDH22 ARVCF ALDH2 HAO2

7.55e-052001167338_DN
Drug2-aminothiophenol

C4A C4B

7.69e-0531162ctd:C005464
Drugdesacetylvinblastine

KDM5D C4A

7.69e-0531162CID000197026
Disease22q11 partial monosomy syndrome

ARVCF GP1BB

5.05e-0491122C3266101
DiseaseAsymmetric crying face association

ARVCF GP1BB

6.30e-04101122C0431406
Disease22q11 Deletion Syndrome

ARVCF GP1BB

6.30e-04101122C2936346
DiseaseEmery-Dreifuss muscular dystrophy (implicated_via_orthology)

LEMD2 HOOK2

9.19e-04121122DOID:11726 (implicated_via_orthology)
Diseaseplatelet crit

CAPN12 STAG1 ANKRD9 LEMD2 TARS2 ARVCF TRABD EIF3A ALDH2 ALDH1B1 PREX1

1.01e-0395211211EFO_0007985
Diseasecreatinine measurement

CAPN12 ATF7 STAG1 ANKRD9 SIPA1L3 JAG2 ULK3 CELSR3 ZNF436-AS1 EIF4B IMP3

1.43e-0399511211EFO_0004518
DiseaseCongenital total cataract

SIPA1L3 LEMD2

1.65e-03161122C0266539
DiseaseDiGeorge Syndrome

ARVCF GP1BB

1.65e-03161122C0012236
DiseaseCONOTRUNCAL ANOMALY FACE SYNDROME

ARVCF GP1BB

1.65e-03161122C0795907
DiseaseShprintzen syndrome

ARVCF GP1BB

1.65e-03161122C0220704
DiseaseNon-alcoholic Fatty Liver Disease

PRF1 ALDH2 ALDH1B1

2.42e-03701123C0400966
DiseaseNonalcoholic Steatohepatitis

PRF1 ALDH2 ALDH1B1

2.42e-03701123C3241937
DiseaseTNF-related apoptosis-inducing ligand measurement

SIPA1L3 TNFRSF10B RNF125

2.62e-03721123EFO_0008300
Diseaseautism spectrum disorder (implicated_via_orthology)

KDM5D ARVCF CHD6 PREX1

2.73e-031521124DOID:0060041 (implicated_via_orthology)
Diseaseresponse to alcohol

DUSP8 WWC2 ALDH2

2.95e-03751123EFO_0005526
Diseaseprostate cancer (is_marker_for)

DAXX MSH2 NCOA4 PREX1

3.00e-031561124DOID:10283 (is_marker_for)

Protein segments in the cluster

PeptideGeneStartEntry
SDRTAVPRELARRLL

URAD

126

A6NGE7
EDARAPGRLARLLRQ

FAM246B

41

A0A494C0N9
AASPLLEDLRRRLTR

AARD

51

Q4LEZ3
ARLDALLAELRAREP

B3GALT6

161

Q96L58
RLARRLRDALREEEP

ANKLE1

6

Q8NAG6
LDRLVRRSPSVDSAR

ARVCF

336

O00192
ALRERAGRLPRLQEE

CCDC88B

321

A6NC98
PRLLRRLEDAARQAR

CTF1

116

Q16619
PRQRRALERGLQDED

C4B

1596

P0C0L5
PRERRNEFSSKERLL

BTN1A1

276

Q13410
LRRREAARAEPRDAR

DUSP8

556

Q13202
RGRLLNRLADLVERD

ALDH1B1

101

P30837
YLRLSDNPRAREALR

CNOT9

236

Q92600
AVRQLRLRRPDDGSR

DLL4

551

Q9NR61
PDERRQRFLERNRAA

ATF7

331

P17544
LDRRLQNLRDRERVP

ZNF436-AS1

31

Q8NC38
PESRRGAQLAERRLR

DNHD1

4426

Q96M86
LERERALARQLLRDG

CHMP6

41

Q96FZ7
RPDRLRDIADRFNVD

DMC1

166

Q14565
DSLVSAQRERPRRRD

DVL3

136

Q92997
ALSDPVLARRLRENR

DAXX

351

Q9UER7
IPARRQRRLFDDTRE

RAB3GAP1

746

Q15042
DAALRQLRSPRRAQA

RAB4A

196

P20338
GLARRLADRARELQE

RIMBP3B

426

A6NNM3
GLARRLADRARELQE

RIMBP3C

426

A6NJZ7
SVRQLSRRFDAPRLD

ARHGEF17

81

Q96PE2
SSDPRLRRLQNRISE

MFAP1

81

P55081
NALPDDLRSPIRAER

NRBP2

201

Q9NSY0
DLRSPIRAEREELRN

NRBP2

206

Q9NSY0
TAPLRRNRRDLVEPD

FRAS1

3841

Q86XX4
CVLRDDLLEARRPRA

ARHGAP45

136

Q92619
RSLERLLEQRRSPER

MAGI1

1401

Q96QZ7
LLARLDARPLAARAA

MAGIX

31

Q9H6Y5
VLDSLRRAQERRELP

GUCY2D

321

Q02846
RRAQERRELPSDLNL

GUCY2D

326

Q02846
RLREEARLREDAPLR

LEMD2

61

Q8NC56
RQLEDELRRAGSLRA

HOOK2

346

Q96ED9
RSLPATRAVARDRLL

JAG2

996

Q9Y219
ARERRFPNSELLQRL

KDM5D

791

Q9BY66
RLALAPDLSTEQRRR

CCDC120

131

Q96HB5
RARARAAARLSLTDP

GP1BB

181

P13224
ELAESGRRLRLPRDQ

MYH14

81

Q7Z406
DLALEPRELAERRVR

PCDHGA9

51

Q9Y5G4
DSQDPRREALRRALS

PRF1

351

P14222
RDARDSRDIRDPRDL

NCOA5

46

Q9HCD5
RDLRDSRDFRDQRDP

NCOA5

91

Q9HCD5
LRRERLARFLNPDEV

FAM83D

51

Q9H4H8
LRREPERLAEERAQL

COG8

61

Q96MW5
QLFEELRRAAPLSRD

PKLR

436

P30613
RLFELADPRDRLELR

KREMEN2

261

Q8NCW0
TRPRALRDLRILAEE

NLRP2

336

Q9NX02
LRPAETARLRALDQA

MIEF1

341

Q9NQG6
LRLRADLELPRDAFT

PAPPA

106

Q13219
RLEDLLLDRGRDALR

CCDC182

131

A6NF36
ARPEDQRRQAATRDL

PKD1L2

991

Q7Z442
LERAAQSDPRRRLSL

PRR35

326

P0CG20
RERQPLLDRARGAAA

PI4K2A

56

Q9BTU6
SSNREPLLRCSDARR

NCOA4

11

Q13772
PLLRCSDARRDLELA

NCOA4

16

Q13772
LRADRSPLSARRDVT

CAPN12

476

Q6ZSI9
TQLRLLEDARDGLRR

CROCC

1161

Q5TZA2
ERPERLTAALDRLRQ

HDAC10

26

Q969S8
NSARDVLRARAPREE

GPR37

61

O15354
DRLSRRADDDRFPRR

EIF3A

1146

Q14152
DERPTRSRRLNDKAR

CHD6

1076

Q8TD26
ARPARRAPDERRQTL

FAM83C

616

Q9BQN1
LRENAFLDREALRLR

CCDC166

56

P0CW27
RRLTLARRDDDPLNA

COL6A2

861

P12110
ARRDDDPLNARVALL

COL6A2

866

P12110
LRDFPAEERARVLDR

ANKRD9

136

Q96BM1
ERLQTDRDRRAALSP

DENND1A

736

Q8TEH3
RELARRLRDLPERDQ

IMP3

56

Q9NV31
RLRDLPERDQFRVRA

IMP3

61

Q9NV31
NPRVERTLLDARRRL

KANK2

121

Q63ZY3
LEPATAAALRRRLDL

KLHDC7B

206

Q96G42
RAQARDRATNRLLEP

CDH22

136

Q9UJ99
DRDPRLRERSLARNS

AHCTF1

981

Q8WYP5
ERRAAAEALRLLRPE

EME2

56

A4GXA9
PELGRRLAELERRLD

EMILIN1

356

Q9Y6C2
RRRALEALRRALEEP

DNAAF5

46

Q86Y56
LRRQLSRERLEEAPA

CELSR3

3076

Q9NYQ7
PARRSAVERLAADRA

FAM110C

31

Q1W6H9
SLQDADRLRRSPLLR

SLC22A31

516

A6NKX4
TLRNPEAREDSKLRR

CDH9

676

Q9ULB4
LQEDLLRRFPDLNRL

MSH2

376

P43246
PRQRRALERGLQDED

C4A

1596

P0C0L4
ARRPRARSVDALDDL

LSR

486

Q86X29
LRFEVRDPRRLQEAR

AGPAT2

76

O15120
APRAAREPNIDRSRL

EIF4B

76

P23588
ARALDLLRRRPEQVD

MIB2

446

Q96AX9
AARPFRRLEASRDQL

TARS2

191

Q9BW92
NDEDALLRRLRGPRV

UTP18

101

Q9Y5J1
RRNDLSLRVERLALA

SIGLEC15

121

Q6ZMC9
AERPALLELERFERR

PPP1R12C

726

Q9BZL4
DDNIAAFKRIRLRPR

HAO2

36

Q9NYQ3
DNCPRVRLRALRLAL

GNRHR2

166

Q96P88
PCAAARESERQLRLR

PREX1

36

Q8TCU6
RLLLAALGRRELDDR

POLR2B

371

P30876
LSLADGRDRPLRRLD

SIPA1L3

1621

O60292
ARLRLQRLPAAQAED

SHCBP1L

66

Q9BZQ2
EALDALPDAERRVRR

NOL3

46

O60936
DEDGSRPLTRLARLR

SRCAP

3056

Q6ZRS2
LRALAQLRRARLEEA

SPTBN5

881

Q9NRC6
ETLSRELEPELRRRR

ALKBH7

46

Q9BT30
RGRLLNRLADLIERD

ALDH2

101

P05091
IRERRLFNLDVPESR

CILP

736

O75339
NPTAVRRRLEALERS

RECQL5

436

O94762
LAAEPVRAKLDRQRR

UBXN6

261

Q9BZV1
RRRFLLLPDAEAQLD

TMEM128

11

Q5BJH2
ERQQEILRRAARALP

ZDHHC20

101

Q5W0Z9
TPSRALAERLRLEER

WWC2

391

Q6AWC2
SATARALERRRDPEL

RNF125

16

Q96EQ8
ARERLERAVSDRLAP

MYCL

101

P12524
FTALRRPSLRREADD

NEURL1

231

O76050
RPSLRREADDARLSV

NEURL1

236

O76050
RLRAEEPGLRRQLSE

SOWAHA

231

Q2M3V2
ARLRLRLDGSDNRND

SCML2

91

Q9UQR0
ARRLELPRASDAEPR

TRABD

271

Q9H4I3
SADRAEELPRRRRPE

SPTBN4

2236

Q9H254
PSRNRRERAELRPDF

STAG1

1226

Q8WVM7
NSARLTPLRYDLRDR

TENM3

2166

Q9P273
VDRIARDLRQRPASL

RRP8

296

O43159
LLEPAEAERSQRRRL

TNFRSF10B

311

O14763
EAERSQRRRLLVPAN

TNFRSF10B

316

O14763
DGQRSRLRPRDDLDR

TRIM14

376

Q14142
RLRPRDDLDRLGVFL

TRIM14

381

Q14142
LLARLQGRDDDARRD

TTC36

131

A6NLP5
RDCRDLLQRLLERDP

ULK3

241

Q6PHR2